T1000	Negation 2156 2159	not
E1000	Negation:T1000 Scope:T1001
T1001	Span 2156 2205	not sufficient to induce proliferation in culture
T1002	Negation 1843 1846	not
E1001	Negation:T1002 Scope:T1003
T1003	Span 1843 1872	not reveal a similar increase
T1004	Negation 2810 2813	not
E1002	Negation:T1004 Scope:T1005
T1005	Span 2810 2840	not enhanced upon IL4 addition
T1006	Speculation 2677 2687	suggesting
E1003	Speculation:T1006 Scope:T1007
T1007	Span 2677 2777	suggesting that even small amounts of LMP1 is sufficient to induce dramatic effects in proliferation
T1008	Negation 530 533	not
E1004	Negation:T1008 Scope:T1009
T1009	Span 530 602	not survive even with the addition of IL4 due to a lack of CD40 ligation
T1010	Speculation 171 178	whether
E1005	Speculation:T1010 Scope:T1011
T1011	Span 171 233	whether LMP1 affects primary B cell survival and proliferation
T1012	Negation 683 690	absence
E1006	Negation:T1012 Scope:T1013
T1013	Span 683 697	absence of IL4
T1014	Negation 581 585	lack
E1007	Negation:T1014 Scope:T1015
T1015	Span 581 614	lack of CD40 ligation (Figure 3A)
T1016	Negation 1201 1208	without
E1008	Negation:T1016 Scope:T1017
T1017	Span 1201 1248	without lymphoma ranged between 6 and 20 mo old
T1018	Negation 837 844	absence
E1009	Negation:T1018 Scope:T1019
T1019	Span 837 863	absence of IL4 (Figure 3A)
T1020	Speculation 1400 1409	indicated
E1010	Speculation:T1020 Scope:T1021
T1021	Span 1400 1509	indicated a 2-fold increase in viability in the LMP1 transgenic lymphocytes compared to wild-type lymphocytes
T1022	Negation 1260 1262	no
E1011	Negation:T1022 Scope:T1023
T1023	Span 1260 1303	no correlation between age and MTS activity
T1024	Speculation 1631 1646	indicating that
E1012	Speculation:T1024 Scope:T1025
T1025	Span 1631 1715	indicating that the lymphoma cells are independent of IL4 co-stimulation (Figure 3B)
T1026	Negation 1599 1602	not
E1013	Negation:T1026 Scope:T1027
T1027	Span 1599 1629	not increased by IL4 treatment
